Table 1 Demographic features, risk factors, stroke classification, clinical assessment, and procedures of ATHS, CES and control group.

From: Th1/Th2 polarization of peripheral immune response in atherothrombotic and cardioembolic stroke: a prospective study

Demographic features and risk factors

ATHS (n = 18)

CES (n = 14)

Controls (n = 30)

Age, median (yr, IQR)

69.2 (11)

73.6 (10)

71.2 (10)

Gender, female, n (%)

11 (61)

7 (50)

19 (63)

Risk Factors

Hypertension, n (%)

15 (83)

11 (79)

22 (73)

Diabetes mellitus, n (%)

10 (56)

9 (64)

15 (50)

Hyperlipidaemia, n (%)

8 (44)

7 (50)

11 (37)

Cigarette smoking, n (%)

7 (39)

6 (42)

11 (37)

Treatments

Antiplatelet therapy prior to stroke, n (%)

10 (56)1

4 (29)1

11 (37)

Anticoagulant therapy prior to stroke, n (%)

0 (0)1

9 (64)1,2

0 (0)2

OCSP1 classification

ACI, n (%)

9 (50)

7 (50)

NA

POCI, n (%)

3 (17)

3 (21)

NA

LACI, n (%)

0 (0)

0 (0)

NA

TACI, n (%)

6 (33)

4 (0)

NA

Clinical assessment and procedures

NIHSS at stroke onset, median (IQR)§

12.4 (8)

11.8 (9)

NA

NIHSS after discharge, median (IQR)§

4.2 (6)

2 (5)

NA

GCS at stroke onset, median (IQR)§

14 (2)

15 (1)

NA

  1. Categorical variables are expressed as number (n) and percentage (%). Numerical variables are expressed as median ± IQR.
  2. OSCP The Oxfordshire Community Stroke Project, PACI partial anterior cerebral infarction, POCI posterior cerebral infarction, LACI lacunar cerebral infarction, TACI total anterior cerebral infarction, NIHSS National Institute of Health Stroke Scale, GCS Glasgow Coma Scale.
  3. 1,2 p < 0.05.
  4. Fisher exact test.
  5. Wilcoxon rank-sum test.
  6. §Mann–Whitney U test.